These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16805710)

  • 1. Adjuvant chemotherapy for early-stage non-small cell lung cancer: the past, the present and the future.
    Potti A; Ganti AK
    Expert Opin Biol Ther; 2006 Jul; 6(7):709-16. PubMed ID: 16805710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
    Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
    Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.
    Bunn PA
    Clin Lung Cancer; 2004 Sep; 6(2):85-98. PubMed ID: 15476594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resected non-small-cell lung cancer stage I/II: indication for adjuvant/neoadjuvant therapy?
    Hoffmann H
    Lung Cancer; 2004 Aug; 45 Suppl 2():S91-7. PubMed ID: 15552788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant Therapy of Resected Non-small Cell Lung Cancer: can We Move Forward?
    Buffoni L; Vavalà T; Novello S
    Curr Treat Options Oncol; 2016 Oct; 17(10):54. PubMed ID: 27523606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant therapy of resected non-small-cell lung cancer.
    Socinski MA
    Clin Lung Cancer; 2004 Nov; 6(3):162-9. PubMed ID: 15555217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current development of adjuvant treatment of non-small-cell lung cancer.
    Scagliotti GV; Novello S
    Clin Lung Cancer; 2004 Dec; 6 Suppl 2():S63-70. PubMed ID: 15638960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical management of early-stage non-small cell lung carcinoma and the present and future roles of adjuvant therapy: a review for the radiation oncologist.
    Medford-Davis L; Decamp M; Recht A; Flickinger J; Belani CP; Varlotto J
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1048-57. PubMed ID: 22632771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant therapy in completely resected non-small-cell lung cancer.
    Scagliotti GV; Novello S
    Curr Oncol Rep; 2003 Jul; 5(4):318-25. PubMed ID: 12781075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant and neoadjuvant therapy for early-stage non-small-cell lung cancer.
    Choong NW; Vokes EE
    Clin Lung Cancer; 2005 Dec; 7 Suppl 3():S98-104. PubMed ID: 16384544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined modality therapy for non-small cell lung carcinoma.
    Machtay M; Glatstein E
    Cancer J; 2002; 8 Suppl 1():S55-67. PubMed ID: 12075703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant treatment of non-small-cell lung cancer: how do we improve the cure rates further?
    Wozniak AJ; Gadgeel SM
    Oncology (Williston Park); 2007 Feb; 21(2):163-71; discussion 171, 174, 179-82. PubMed ID: 17396481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emergence of a unique population in non-small cell lung cancer: systemic or loco-regional relapse following postoperative adjuvant platinum-based chemotherapy.
    Socinski MA; Stinchcombe TE; Hayes DN; Morris DE
    Semin Oncol; 2006 Feb; 33(1 Suppl 1):S32-8. PubMed ID: 16472707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant and neoadjuvant chemotherapy for non-small cell lung cancer: a time for reassessment?
    Bunn PA; Mault J; Kelly K
    Chest; 2000 Apr; 117(4 Suppl 1):119S-122S. PubMed ID: 10777465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant chemotherapy for surgically resected non-small cell lung cancer.
    Heon S; Johnson BE
    J Thorac Cardiovasc Surg; 2012 Sep; 144(3):S39-42. PubMed ID: 22502967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized phase II study to assess the effect of adjuvant immunotherapy using α-GalCer-pulsed dendritic cells in the patients with completely resected stage II-IIIA non-small cell lung cancer: study protocol for a randomized controlled trial.
    Saka H; Kitagawa C; Ichinose Y; Takenoyama M; Ibata H; Kato T; Takami K; Yamashita M; Maeda T; Takeo S; Ueda H; Okabayashi K; Nagashima S; Oka T; Kouso H; Fukuyama S; Yoshimoto K; Shimokawa M; Saito AM; Ito S
    Trials; 2017 Sep; 18(1):429. PubMed ID: 28915900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does adjuvant chemotherapy decrease distant metastasis formation in patients with non-small cell lung cancer?
    Green MR
    Lung Cancer; 1994 Mar; 10 Suppl 1():S187-94. PubMed ID: 8087509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined modality therapy of non-small cell lung cancers.
    Juretic A; Sobat H; Samija M
    Ann Oncol; 1999; 10 Suppl 6():93-8. PubMed ID: 10676559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer.
    Johnson BE; Rabin MS
    Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5022s-5026s. PubMed ID: 16000607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.